5 Stocks Down More Than 50% From Their Record Highs to Buy Now

The article highlights five consumer-goods stocks trading roughly 50%–89% below their record highs, each with a potential business catalyst and meaningful risks. Hormel agreed to buy Brakebush Brothers for about $1.055 billion; Helen of Troy raised adjusted EPS guidance to $3.60–$4.15 and received $26.9 million in tariff refunds; Freshpet raised its 2026 sales-growth outlook to 10%–12%; and Yeti set fiscal 2030 targets including $1.2–$1.4 billion of cumulative free cash flow. The outlook is mixed: acquisitions, growth initiatives, and cost reductions could support recovery, but debt, category pressure, and execution risks remain.

Analysis

These are five different underwriting problems, not a single “fallen consumer stocks” opportunity. Near term, headline catalysts may lift sentiment, but durable rerating requires evidence of volume, gross-margin recovery, and cash conversion—not management targets or one-time tariff proceeds.

HELE has the clearest near-term setup, but the key test is whether raised adjusted EPS converts into organic demand and debt reduction after tariff refunds roll off. If not, the low multiple may reflect structurally weaker brands or margins rather than mispricing. HRL’s deal could diversify protein exposure, yet adds execution and leverage risk just as poultry economics and integration costs matter; sales scale alone does not establish accretion quality. ENR’s restructuring may improve cash generation, but validate actual cash costs and debt paydown before capitalizing the dividend yield.

FRPT’s installed fridges could create a distribution moat, but they also require ongoing capital and shelf-space productivity. In a pressured consumer, trading down or low turns can weaken returns even if household penetration rises. YETI’s bag expansion offers diversification but risks brand dilution, inventory buildup, and competing for discretionary spending; buybacks do not validate product-market fit.

Over 1–3 months, watch earnings for organic volume, margins, inventory, and free cash flow. Over 6–18 months, the differentiators are HRL integration, HELE’s post-refund earnings quality, ENR’s realized restructuring savings, and FRPT/YETI returns on expansion. The contrarian point: drawdowns alone are not catalysts; the strongest signal is measurable cash economics improving before the market’s narrative does.

Key Decisions for Investors

• HELE: consider a small, staged long only if the next report confirms sales/volume progress and debt reduction without relying on tariff refunds. Falsify on renewed sales deterioration, weaker guidance, or stalled deleveraging; do not underwrite the adjusted-EPS multiple as a floor.
• HRL: stay watchful rather than buying the acquisition headline. Reassess after closing and early integration disclosures; require evidence on financing, acquired-business profitability, and consolidated cash flow. Higher leverage or weak poultry economics would argue against the thesis.
• ENR: treat the dividend and restructuring as a verification trade, not a yield screen. Track restructuring cash outlays, free cash flow, and debt paydown; defer adding if savings fail to appear as costs step down.
• FRPT and YETI: avoid extrapolating penetration or 2030 targets into near-term earnings. For FRPT, monitor fridge productivity and cash generation; for YETI, monitor bags/soft-cooler sell-through and inventory. Consider positions only after those metrics validate expansion returns.